CHRONO THERAPEUTICS, INC.
Programmable transdermal nicotine delivery device integrated with behavioral support mobile app for smoking cessation
- Sector
- Medtech
- Headquarters
- HAYWARD, CA
- Latest Form D
- $37.6M, Sep 2016
- Total capital
- $57.5M
- Federal grants
- $6.2M
- 5 awards · 2015–2018
- Rank in peer group#112 of 538
- Private capital raised
- $51.4M
- 3 Form D · last Sep 2016
- 122 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 8
- 16 pending · first 2016
- Rank in peer group#74 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Programmable Individualized NRT Merged With Digital Behavioral Support$1M
- Federal grantHealth and Human S · Phase II · Programmable Individualized NRT Merged With Digital Behavioral Support$2M
- Federal grantHealth and Human S · Phase II · Tailored NRT Integrated with Smartphone Behavioral Support$1M
- Private capital raisedForm D · SEC · 3rd filing$37.6M
- Federal grantHealth and Human S · Phase II · Tailored NRT Integrated with Smartphone Behavioral Support$2M
- Federal grantHealth and Human S · Phase II · Tailored NRT Integrated with Smartphone Behavioral Support$155K
- Private capital raisedForm D · SEC · 2nd filing$13.3M
- Private capital raisedForm D · SEC · 1st filing$500K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#112 · top 21%
- Granted patents#74 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- GUY DIPIERROResearcherExecutive Officer, DirectorLinked by 4 patents
- ALAN LEVYResearcherExecutive Officer, DirectorLinked by $2M in grants as PI
- AIDAN W. KINGDirectorNamed in SEC Form D filings
- ALAN LEVY, PH.D.Executive Officer, DirectorNamed in SEC Form D filings
- ANTHONY RIMACExecutive OfficerNamed in SEC Form D filings
- ELIZABETH W. ROCKETTDirectorNamed in SEC Form D filings
Show all 10 people
- JAMES W. YOUNGDirectorNamed in SEC Form D filings
- STEVEN W. JAMESDirectorNamed in SEC Form D filings
- TIM W. KILGALLONDirectorNamed in SEC Form D filings
- WENDE W. HUTTONDirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 24- PendingMethods And Devices For Treating Levodopa Induced DyskinesiaUSPTOApplication 16474083
- PendingTransdermal Drug Delivery Devices And MethodsUSPTOApplication 16484477
- PendingTransdermal Drug Delivery Device For Delivering OpioidsUSPTOApplication 16330111
Show all 24 patent records
- Methods And Devices For Treating Levodopa Induced DyskinesiaNov 26, 2020 · Application 16474083Pending
- Transdermal Drug Delivery Devices And MethodsJan 30, 2020 · Application 16484477Pending
- Transdermal Drug Delivery Device For Delivering OpioidsAug 1, 2019 · Application 16330111Pending
- Biosynchronous Transdermal Drug Delivery For Longevity, Anti-aging, Fatigue Management, Obesity, Weight Loss, Weight Management, Delivery Of Nutraceuticals, And The Treatment Of Hyperglycemia, Alzheimer's Disease, Sleep Disorders, Parkinson's Disease, Aids, Epilepsy, Attention Deficit Disorder, Nicotine Addiction, Cancer, Headache And Pain Control, Asthma, Angina, Hypertension, Depression, Cold, Flu And The LikeApr 16, 2019 · US 10,258,778Granted
- Drug Delivery Methods And SystemsMar 19, 2019 · US 10,232,156Granted
- Drug Delivery Methods And SystemsFeb 26, 2019 · US 10,213,586Granted
- Craving Input And Support SystemDec 27, 2018 · Application 16115415Pending
- Optimized Bio-synchronous Bioactive Agent Delivery SystemOct 23, 2018 · US 10,105,487Granted
- Biosynchronous Transdermal Drug Delivery For Longevity, Anti-aging, Fatigue Management, Obesity, Weight Loss, Weight Management, Delivery Of Nutraceuticals, And The Treatment Of Hyperglycemia, Alzheimer's Disease, Sleep Disorders, Parkinson's Disease, Aids, Epilepsy, Attention Deficit Disorder, Nicotine Addiction, Cancer, Headache And Pain Control, Asthma, Angina, Hypertension, Depression, Cold, Flu And The LikeJun 6, 2017 · US 9,669,199Granted
- Biosynchronous Transdermal Drug DeliveryApr 13, 2017 · Application 15385665Pending
- Biosynchronous Transdermal Drug DeliveryJan 31, 2017 · US 9,555,227Granted
- Transdermal Drug Delivery Method And SystemJan 31, 2017 · US 9,555,226Granted
- Portable Drug Delivery Device Including A Detachable And Replaceable Administration Or Dosing ElementNov 29, 2016 · US RE46,217Granted
- Transdermal Drug Delivery System And MethodJul 24, 2014 · Application 14156944Pending
- Biosynchronous Transdermal Drug DeliveryJul 17, 2014 · Application 14162156Pending
- Optimized Bio-synchronous Bioactive Agent Delivery SystemApplication PCTUS2014012491Pending
- Transdermal Drug Delivery Device For Delivering OpioidsApplication PCTUS2017054093Pending
- Smart Abuse-deterrent Transdermal Drug Delivery SystemApplication PCTUS2018059026Pending
- Transdermal Drug Delivery Devices And MethodsApplication PCTUS2017064765Pending
- Transdermal Drug Delivery Devices And MethodsApplication PCTUS2018012568Pending
- Craving Input And Support SystemApplication PCTUS2016022117Pending
- Drug Delivery Methods And SystemsApplication PCTUS2016015469Pending
- Methods And Devices For Treating Levodopa Induced DyskinesiaApplication PCTUS2018012646Pending
- Transdermal Drug Delivery System And MethodApplication PCTUS2014012465Pending
Related companies, and why
- ALDATU BIOSCIENCES INCSimilar federal contract value in Medtech · null in contracts
- REBISCAN, LLCSimilar federal contract value in Medtech · null in contracts
- Applied Research and PhotonicsSimilar federal contract value in Medtech · null in contracts
- HEMEX HEALTH INCSimilar federal contract value in Medtech · null in contracts
- Spinethera, Inc.Similar federal contract value in Medtech · null in contracts
- IKONISYS INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .